Increased circulating asymmetric dimethylarginine (ADMA) levels in active stage of Behçet’s Syndrome
Küçük Resim Yok
Tarih
2009
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Thieme Publishing Group
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
There is little evidence in the literature about circulating asymmetric dimethylarginine (ADMA) levels in Behçet's syndrome (BS). The aim of the present study was 1. to measure the levels of ADMA in male patients with BS, 2. to compare ADMA levels with healthy volunteers, and 3. to evaluate whether there is any difference between patients both with / without thrombosis and in active / inactive stage. In patients with BS, CRP levels were higher than controls. The mean ADMA and C-reactive protein (CRP) levels were significantly higher in active stage patients and patients with thrombosis than in patients during the inactive stage and without thrombosis. In conclusion, we did not find any significant difference in ADMA levels between patients with BS and healthy controls. Serum ADMA concentrations, however,
Açıklama
Anahtar Kelimeler
Behçet's disease, asymmetric dimethylarginine, endothelial dysfunction, thrombosis, active stage
Kaynak
Aktuelle Rheumatologie
WoS Q Değeri
Scopus Q Değeri
Q4
Cilt
34
Sayı
2
Künye
Terekeci, M. H., Nalbant, S., Özgürtaş, T., Çelik, S., Tapan, S., Sanisoğlu, Y. S., Şahan, B., Sayan, Ö., Küçükardalı, Y., Top, C. ve Öktenli, Ç. (2009). Increased circulating asymmetric dimethylarginine (ADMA) levels in active stage of Behçet’s Syndrome. Aktuelle Rheumatologie, Thieme Publishing Group. 34(2), s. 121-125.
